SightfileU.S. market data from official filings

Companies › EOLS

EVOLUS INC (EOLS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001570562 · EDGAR filings · Updated 2026-07-08

EVOLUS INC (EOLS) has reported institutional ownership of 69.3%, with 147 institutional managers holding positions valued at $188.3M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
69.3%
Institutional managers
147
Reported 13F value
$188.3M
Insider activity
25 trans.
−$2.08M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, EVOLUS INC has 147 institutional holders and institutional ownership of 69.3%.

Insider activity

Insiders reported 25 transactions (2 buys, 12 sells) across 10 reporting insiders, with a net reported value of −$2.08M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2021-03-25 (recurring since 2021-03-25) — source filing. The authoritative details are those stated in the filing itself.

Related companies

INHIBIKASE THERAPEUTICS INC (IKT) · ALECTOR INC (ALEC) · ALX ONCOLOGY HLDGS INC (ALXO) · ARCTURUS THERAPEUTICS HLDGS (ARCT) · AUTOLUS THERAPEUTICS LTD (AUTL) · SIGA TECHNOLOGIES INC (SIGA)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-08.